Skip to main content
. 2018 Sep 18;2:35. Originally published 2018 Jul 25. [Version 2] doi: 10.12688/gatesopenres.12842.2

Figure 1. Xpert MTB/RIF market penetration in the public sector of 21 high TB burden countries (2014–2016).

Figure 1.

South Africa decreased its smear/Xpert ratio by 100%, therefore has achieved the highest market penetration of Xpert MTB/RIF in the public sector. Countries are listed in order of greatest percent decrease in smear/Xpert ratio from 2014–2016. Arrows represent percent changes in smear/Xpert ratios 2014–2016. Trends moving closer to 0 (ratio decreasing) signify a greater use of Xpert compared to smear microscopy for the diagnosis of TB. Trends moving away from 0 (ratio increasing) signify a greater use of smear microscopy compared to Xpert for the diagnosis of TB.